It is the cache of ${baseHref}. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Rational Pharmacotherapy in CardiologyAntithrombotic therapy in nonvalvular atrial fibrillation: problems and prospects

Antithrombotic therapy in nonvalvular atrial fibrillation: problems and prospects

A.Y. Rychkov*, N.Y. Khor'kova, A.A. Bliznyakov

Branch of the Research Institute of Cardiology of the Siberian branch of the Russian Academy of Medical Science “Tyumen Cardiology Center”.

Melnikaite ul. 111, Tyumen, 625026 Russia

Appropriate use of warfarin is not in routine clinical practice despite convincing data of clinical studies on the possibility of effective reduction in frequency of thromboembolic complications associated with nonvalvular atrial fibrillation, particularly ischemic stroke. Confirmation of the efficacy and implementation of measures related to the effect on blood clotting and providing basically new possibilities to reduce the risk of ischemic events expected in the near future.

Key words: atrial fibrillation, stroke prevention, warfarin, antithrombotic therapy.

Rational Pharmacother. Card. 2010;6(4):522-527

* Corresponding author: rychkov@cardio.tmn.ru


Download free full text (PDF)

© 2007 — 2014 «Rational Pharmacotherapy in Cardiology»
«Stolichnaya Izdatelskaya Kompaniya»

ISSN 1819-6446(Print) ISSN 2225-3653 (Online)